证券代码：300253 证券简称：卫宁健康 卫宁健康科技集团股份有限公司 投资者关系活动记录表 编号：2018-001 | --- | --- | --- | |-------------------------|----------------------------------------------|------------------------------------------------------------------------------------------------------| | | | | | | | | | 投资者关系活动 | √ | 特定对象调研 □分析师会议 | | 类别 | □媒体采访 □业绩说明会 □ 新闻发布会 □路演活动 | | | | | | | | □现场参观 | | | | □ | 其他 （请文字说明其他活动内容） | | 参与单位名称及 人员姓名 | 立溢投资 - | 王科；国泰君安 - 徐紫薇、郑宇舟；新时代证券-刘 航；中信产业基金-翁林开；方正证券-付然；银河证券-钱劲 | | | | | | | | 宇；海通证券-鲁立；仁布投资-鲍炜；长信基金 ...

Financial Performance - In 2019, the company achieved a revenue of 1,908.01 million CNY, a year-on-year growth of 33% [3] - Net profit attributable to shareholders was 398.42 million CNY, up 31% year-on-year [3] - The net profit after deducting non-recurring gains and losses was 341.78 million CNY, reflecting a 23% increase [3] - Operating cash flow net amount reached 2,333.01 million CNY, with an 88% year-on-year growth [3] - The company's average compound annual growth rates over the past decade are 33% for revenue, 31% for net profit, and 27% for operating cash flow [3] Market Position and Comparison - The company ranks 33rd among the global healthcare technology firms, with Cerner being its overseas benchmark, ranked 2nd [4] - Cerner's revenue in 2019 was approximately 5.693 billion USD, which is 334.88 times its revenue at the time of its IPO in 1986 [4] - The company's software gross margin in 2019 was 64%, indicating potential for improvement compared to Cerner's gross margin exceeding 80% [4] Future Growth and Challenges - The company expects a stable revenue growth of 10%-15% in Q1 2020, which is the lowest quarterly growth since its IPO [4] - The decline in revenue growth is attributed to the impact of the COVID-19 pandemic, which affected on-site work and project implementations [4] - The company anticipates a net profit growth of approximately -8% to +10% for Q1 2020, adjusting for specific factors such as government subsidies and tax issues [4] Innovation and New Business - The company has established over 100 internet hospitals in collaboration with physical hospitals, indicating a strong growth trajectory in telemedicine [5] - The cloud-based medical services and insurance projects are progressing rapidly, with expectations for significant long-term growth [5] - The company is focusing on a cooperative model for internet hospitals, which is expected to yield substantial benefits in the future [5] Industry Insights - The average budget allocation for hospital information technology in China is 1.13% of the total budget, showing room for growth in healthcare IT investments [4] - The current level of electronic medical record implementation in China is estimated to be around 2.1, indicating a significant gap compared to the US [4] - The company believes that the overall investment in healthcare IT will increase, driven by government policies and the ongoing need for improved healthcare infrastructure [6]

证券代码：300253 证券简称：卫宁健康 卫宁健康科技集团股份有限公司 投资者关系活动记录表 编号：2020-001 | --- | --- | --- | |-------------------------|------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...

Group 1: Company Strategy and Business Model - The company implements a dual-driven development strategy, focusing on traditional medical information services and innovative health services through the "4+1" model, which includes cloud medical, cloud pharmacy, cloud insurance, cloud health, and an innovation service platform [4][5]. - The traditional business is expected to maintain a growth rate of 40%, driven by a large user base of over 5,000 medical users and continuous investment in R&D [6][11]. - The innovative business aims to leverage existing user resources to expand into new markets, with a focus on integrating services and creating new business models [4][5]. Group 2: Financial Performance and Projections - The company's net profit for 2017 is projected to be between 205 million and 238 million CNY, representing a year-on-year growth of 25% to 45% [4]. - The cloud pharmacy service has seen a significant increase in premium scale, growing over 5 times in 2017, with expectations of turning profitable in 2018 [5][9]. - The company anticipates strong support for traditional business growth from national health policies, particularly the "Healthy China 2030" initiative [4]. Group 3: Market Expansion and User Engagement - The cloud medical service has rapidly expanded, covering over 1,000 medical institutions and hundreds of thousands of doctors across more than 20 provinces [5]. - The cloud insurance service has been implemented in over 150 hospitals, facilitating data sharing with commercial insurance companies [10]. - The company is actively working to integrate its services with third-party medical institutions, enhancing user engagement and data flow [7][8]. Group 4: Challenges and Industry Dynamics - The company faces challenges in maintaining long-term growth in traditional business due to market competition and the need for continuous innovation [6][12]. - The healthcare information technology market is still fragmented, allowing opportunities for smaller companies to be replaced by more comprehensive solutions [11][12]. - Regulatory policies significantly impact the development of healthcare information systems, with hospitals increasingly investing in IT to meet compliance and operational efficiency [12][13].

证券代码：300253 证券简称：卫宁健康 卫宁健康科技集团股份有限公司 投资者关系活动记录表 编号：2020-003 | --- | --- | --- | |--------------|----------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | | | | | 别 | □ | 媒体采访 □业绩说明会 | | 参与单位名称 | □ □ 现场参观 □ | 新闻发布会 □路演活动 其他（请文字说明其他活动内容） 安信基金、安信证券、安信资管、白 ...

证券代码：300253 证券简称：卫宁健康 | --- | --- | --- | |------------------|-----------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ...

证券代码：300253 证券简称：卫宁健康 卫宁健康科技集团股份有限公司 投资者关系活动记录表 编号：2019-001 | --- | --- | --- | |-------------------------|-----------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...

证券代码：300253 证券简称：卫宁健康 卫宁健康科技集团股份有限公司 投资者关系活动记录表 编号：2018-003 | --- | --- | --- | |------------------|-------|--------------------------| | | | | | 投资者关系活动类 | √ | 特定对象调研 □分析师会议 | | --- | --- | |-----------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...

证券代码：300253 证券简称：卫宁健康 卫宁健康科技集团股份有限公司 投资者关系活动记录表 编号：2018-004 | --- | --- | |-------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...

证券代码：300253 证券简称：卫宁健康 卫宁健康科技集团股份有限公司 投资者关系活动记录表 编号：2018-005 | --- | --- | --- | |-------------------------|---------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...